The whole sharemarket is in doldrums. Only a few type of shares have the potential to ride through stormy weather. RRS COULD BE one of them with the magic touch.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%